Search research articles
Contact Us
Filters
Showing results (751-760 of 1,385) with videos related to
Page
of 139
Sort By:
Psychiatry Research
|
July 18, 2015
Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia
Robin Emsley, Laila Asmal, Bonginkosi Chiliza, et al.
Psychiatry Research
|
September 1, 1991
Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients
P D Harvey, K M Putnam, M Davidson, et al.
Acta Psychiatrica Scandinavica
|
September 16, 2018
Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis
C Okhuijsen-Pfeifer, E A H Huijsman, A Hasan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 25, 2007
Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia
Jan-Willem Muntjewerff, Henkjan Gellekink, Martin den Heijer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 26, 2007
Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia
M P M Boks, T Rietkerk, M H van de Beek, et al.
The Journal of Clinical Psychiatry
|
June 27, 2007
Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study
René S Kahn, S Charles Schulz, Veselin D Palazov, et al.
Archives of General Psychiatry
|
January 1, 1991
Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation
M Davidson, R S Kahn, P Powchik, et al.
Psychopharmacology
|
March 25, 2015
Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum
Matthijs G Bossong, Mitul A Mehta, Bart N M van Berckel, et al.
Plos One
|
July 31, 2012
Oscillatory cortical network involved in auditory verbal hallucinations in schizophrenia
Remko van Lutterveld, Arjan Hillebrand, Kelly M J Diederen, et al.
Frontiers in Human Neuroscience
|
July 16, 2010
Human fronto-tectal and fronto-striatal-tectal pathways activate differently during anti-saccades
Antoin D de Weijer, Rene C W Mandl, Iris E C Sommer, et al.
Page
of 139
Search research articles
Search
Showing results (751-760 of 1,385) with videos related to
Sort By:
Page
of 139
Psychiatry Research
|
July 18, 2015
Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia
Robin Emsley, Laila Asmal, Bonginkosi Chiliza, et al.
Psychiatry Research
|
September 1, 1991
Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients
P D Harvey, K M Putnam, M Davidson, et al.
Acta Psychiatrica Scandinavica
|
September 16, 2018
Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis
C Okhuijsen-Pfeifer, E A H Huijsman, A Hasan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 25, 2007
Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia
Jan-Willem Muntjewerff, Henkjan Gellekink, Martin den Heijer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 26, 2007
Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia
M P M Boks, T Rietkerk, M H van de Beek, et al.
The Journal of Clinical Psychiatry
|
June 27, 2007
Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study
René S Kahn, S Charles Schulz, Veselin D Palazov, et al.
Archives of General Psychiatry
|
January 1, 1991
Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation
M Davidson, R S Kahn, P Powchik, et al.
Psychopharmacology
|
March 25, 2015
Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum
Matthijs G Bossong, Mitul A Mehta, Bart N M van Berckel, et al.
Plos One
|
July 31, 2012
Oscillatory cortical network involved in auditory verbal hallucinations in schizophrenia
Remko van Lutterveld, Arjan Hillebrand, Kelly M J Diederen, et al.
Frontiers in Human Neuroscience
|
July 16, 2010
Human fronto-tectal and fronto-striatal-tectal pathways activate differently during anti-saccades
Antoin D de Weijer, Rene C W Mandl, Iris E C Sommer, et al.
Page
of 139